A prognostic clinical and circulating biomarker model to identify futile chemo-radiotherapy (CRT) in stage III NSCLC

被引：0
|
作者：
Vaes, R. D. W. [1 ]
Hendriks, L. [2 ]
Houben, R. [1 ]
Degens, J. [3 ]
Cortiula, F. [4 ]
De Ruysscher, D. [1 ]
机构：
[1] Maastro Clin, Dept Radiat Oncol MAASTRO, Maastricht, Netherlands
[2] Maastricht Univ, Dept Pulm Dis, Med Ctr MUMC, Maastricht, Netherlands
[3] Zuyderland Med Ctr, Dept Pulm Dis, Geleen, Netherlands
[4] Univ Hosp Udine, Dept Med Oncol, Udine, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.779
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1301P
引用
收藏
页码：S749 / S749
页数：1
相关论文
共 50 条
  • [1] Mutation Profile Prognostic Value in Stage III Non Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy (CRT)
    Boros, Angela
    Lacroix, Ludovic
    Lancas, Benjamin
    Adam, Julien
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    De Montpreville, Vincent
    Deutsch, Eric
    Besse, Benjamin
    Le Pechoux, Cecile
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S288 - S288
  • [2] Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT)
    Adam, J.
    Boros, A.
    Lacas, B.
    Lacroix, L.
    Pignon, J. P.
    Caramella, C.
    Planchard, D.
    Levy, A.
    Besse, B.
    Le Pechoux, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S604 - S604
  • [3] Predictive factors for 90 day mortality in stage III NSCLC patients treated with chemo-radiotherapy
    Lambrecht, M.
    Van de Velde, A.
    Verfaillie, S.
    Defraene, G.
    Berkovic, P.
    Dooms, C.
    Vansteenkiste, J.
    Wauters, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1052 - S1053
  • [4] MVP versus (vs) MVP plus chemo-radiotherapy in stage III NSCLC: Preliminary results
    Rebischung, JL
    Vannetzel, JM
    Sauvaget, J
    LeroyTerquem, E
    LeRoll, A
    Vetillard, D
    Pariente, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1062 - 1062
  • [5] Efficacy of Chemo-Radiotherapy (CRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression
    Adam, Julien
    Boros, Angela
    Lacas, Benjamin
    Lacroix, Ludovic
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    Besse, Benjamin
    Le Pechoux, Cecile
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S244 - S244
  • [6] SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy
    Kurtul, Neslihan
    Tasdemir, Erdem Arzu
    Unal, Dilek
    Izmirli, Mustafa
    Eroglu, Celalettin
    [J]. CANCER BIOMARKERS, 2017, 18 (04) : 459 - 466
  • [7] clinical prognostic factors for esophageal cancer treated with definitive chemo-radiotherapy
    Favareto, S.
    Sousa, C.
    Pinto, P.
    Ramos, H.
    Neto, E.
    Abrahao, C.
    Chen, M.
    Pellizzon, A. C.
    Silva, M. L.
    Gondim, G.
    Castro, D.
    Fogaroli, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1091 - S1092
  • [8] Monitoring engorgement of phagocytic circulating stromal cells during chemo-radiotherapy induction predicts survival in unresectable stage 2/3 NSCLC
    Gardner, Kirby P.
    Adams, Daniel L.
    Bravo, Pablo Lopez
    He, Jianzhong
    Qiao, Yawei
    Xu, Ting
    Liao, Zhongxing X.
    Tang, Cha-Mei
    Lin, Steven H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Sarcopenia evolution in stage III lung cancer treated with photon or proton chemo-radiotherapy
    Angrisani, A.
    Hattu, D.
    Hendriks, L.
    Peeters, S.
    Reymen, B.
    Van Loon, J.
    Verhoeven, K.
    Ven, L. In T.
    Dhont, J.
    De Ruysscher, D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S679 - S679
  • [10] Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value
    Boros, A.
    Lacroix, L.
    Lacas, B.
    Adam, J.
    Pignon, J. P.
    Caramella, C.
    Planchard, D.
    Levy, A.
    Montpreville, V.
    Deutsch, E.
    Besse, B.
    Le Pechoux, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S595 - S595
12345